TNFRSF11A and breast cancer: Higher concentrations of soluble RANKL are positively correlated with an increased risk of estrogen receptor-positive but not estrogen receptor-negative breast cancer, indicating that the RANK/RANKL/OPG axis may be involved in the tumorigenesis of ER+ breast cancer (83).